The AHSN Network Innovator Offer provides a consistent level of service to innovators seeking support from AHSNs. All AHSNs have agreed to provide the services set out in the Universal, Enhanced and Distinctive tiered structure.
UNIVERSAL: Four core services are available to all innovators including UK and international. This is the foundation block of the Office for Life Sciences (OLS) commission (Level 1 support). The Universal offer has been designed to map closely to the requirements of the NHS Innovation Service, to be launched in 2022.
- Review and respond
- Assess and triage
- Advise, guide and support
- Develop health and care understanding
ENHANCED: Fourteen services are available to selected innovators where the solution meets a local priority or unmet need. The purpose of the Enhanced offer is to give innovators access to a suite of practical support options which will enable them to develop their innovation. Transition to Enhanced Offer is guided by meeting the AHSN threshold, e.g. local demand or priority. Our local priority areas are:
- Mental health
- Cardiovascular disease/stroke
- Early cancer detection
- Maternity and neonatal
- Elective recovery
DISTINCTIVE: A distinctive offer is a unique service provided depending on resource availability and specialist skills held within the AHSN. Each AHSN has its own unique service offerings and can provides these services on a case-by-case basis. Our distinctive services are:
- Bid writing support
- Evaluation delivery support
- Early health economic evaluation
- Lean Assessment Process methodology
The £140m AI in Health and Care Award offers funding across four phases: feasibility, development, real world testing and initial adoption in the NHS. The Oxford AHSN supported seven of the 42 successful bids worth £5m in Rounds 1 and 2.
Contact email@example.com to discuss support for grant funding applications.